Kestra Medical Technologies, Ltd.
KMTS
$20.70
$1.115.67%
NASDAQ
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.81% | 16.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.81% | 16.49% | |||
| Cost of Revenue | 4.53% | 5.90% | |||
| Gross Profit | 12.97% | 29.07% | |||
| SG&A Expenses | 11.48% | 13.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.20% | 12.58% | |||
| Operating Income | -9.48% | -9.96% | |||
| Income Before Tax | -4.21% | -26.98% | |||
| Income Tax Expenses | 2.94% | 3.03% | |||
| Earnings from Continuing Operations | -4.21% | -26.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.21% | -26.95% | |||
| EBIT | -9.48% | -9.96% | |||
| EBITDA | -11.57% | -9.43% | |||
| EPS Basic | 4.12% | -26.76% | |||
| Normalized Basic EPS | 4.12% | -26.80% | |||
| EPS Diluted | 4.12% | -26.76% | |||
| Normalized Diluted EPS | 4.12% | -26.80% | |||
| Average Basic Shares Outstanding | 8.70% | 0.14% | |||
| Average Diluted Shares Outstanding | 8.70% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||